Steven Ferrucci
Optometrist · Sepulveda, CANPI 1225053267
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.9%. Reporting peaked in 2019 at $102,023 and has fallen 57.8% since, to $43,023 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 350 payments — averaging $777.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$43K
- Alcon$40K
- Astellas Pharma US Inc$39K
- Maculogix, Inc.$34K
- Genentech USA, Inc.$32K
- Regeneron Healthcare Solutions, Inc.$30K
- plus $54K from 15 others
Across 2 payments — averaging $10,156 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$20K
What the payments were for
- Consulting fees$67,70725%
- Speaking & faculty fees$157,13958%
- Travel & lodging$34,62713%
- Food & beverage$12,7065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 40 | $43,239 |
| Alcon | 80 | $40,388 |
| Astellas Pharma US Inc | 56 | $38,649 |
| Maculogix, Inc. | 23 | $33,693 |
| Genentech USA, Inc. | 49 | $32,197 |
| Regeneron Healthcare Solutions, Inc. | 56 | $29,758 |
| LKC Technologies, Inc. | 14 | $26,543 |
| Optovue, Inc. | 10 | $12,869 |
| Bausch & Lomb Americas Inc. | 5 | $5,518 |
| F. Hoffmann-la Roche AG | 2 | $4,841 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $2,062 |
| Regeneron | 1 | $1,180 |
| Notal Vision, Inc. | 1 | $500 |
| Topcon Healthcare, Inc. | 2 | $200 |
| Genentech, Inc. | 2 | $181 |
| Sight Sciences, Inc. | 2 | $113 |
| Kala Pharmaceuticals, Inc. | 1 | $102 |
| Visionix USA, Inc | 1 | $44 |
| Sun Pharmaceutical Industries Inc. | 1 | $43 |
| Astellas Pharma Global Development | 1 | $30 |
| Tarsus Pharmaceuticals, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$272,179 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.
Other optometrist in Sepulveda
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Katie ChuRosemead$271K
- Heidi PhamSacramento$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.